vascular events: a meta-analysis of individual patient data from randomized controlled trials. Stroke. 2005 Jan;36(1):162-8. \[[PubMed: 15569877](https://pubmed.ncbi.nlm.nih.gov/15569877)\] 6. Sacco RL, Diener HC, Yusuf S, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha L, Dahlöf B, De Keyser J, Donnan GA, Estol C, Gorelick P, Gu V, Hermansson K, Hilbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R, Skvortsova V, Teal P, Toni D, Vandermaelen C, Voigt T, Weber M, Yoon BW., PRoFESS Study Group. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med. 2008 Sep 18;359(12):1238-51. \[[PMC free article: PMC2714259](/pmc/articles/PMC2714259/)\] \[[PubMed: 18753638](https://pubmed.ncbi.nlm.nih.gov/18753638)\] 7. Pouleur H, Buyse M. Effects of dipyridamole in combination with anticoagulant therapy on survival and thromboembolic events in patients with prosthetic heart valves. A meta-analysis of the randomized trials. J Thorac Cardiovasc Surg. 1995 Aug;110(2):463-72. \[[PubMed: 7637364](https://pubmed.ncbi.nlm.nih.gov/7637364)\] 8. Chesebro JH, Fuster V, Elveback LR, McGoon DC, Pluth JR, Puga FJ, Wallace RB, Danielson GK, Orszulak TA, Piehler JM, Schaff HV. Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole. Am J Cardiol. 1983 May 15;51(9):1537-41. \[[PubMed: 6342354](https://pubmed.ncbi.nlm.nih.gov/6342354)\] 9. Picano E, Sicari R, Varga A. Dipyridamole stress echocardiography. Cardiol Clin. 1999 Aug;17(3):481-99, viii. \[[PubMed: 10453294](https://pubmed.ncbi.nlm.nih.gov/10453294)\] 10. Vidal I, Beretta M, Alonso O, Mut F. New exercise-dipyridamole combined test for nuclear cardiology in insufficient effort: appropriate diagnostic sensitivity keeping exercise prognosis. Arq Bras Cardiol. 2015 Aug;105(2):123-9. \[[PMC free article: PMC4559120](/pmc/articles/PMC4559120/)\] \[[PubMed: 26039661](https://pubmed.ncbi.nlm.nih.gov/26039661)\] 11. Harker LA, Kadatz RA. Mechanism of action of dipyridamole. Thromb Res Suppl. 1983;4:39-46. \[[PubMed: 6356465](https://pubmed.ncbi.nlm.nih.gov/6356465)\] 12. Kim HH, Liao JK. Translational therapeutics of dipyridamole. Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):s39-42. \[[PMC free article: PMC2615560](/pmc/articles/PMC2615560/)\] \[[PubMed: 18174451](https://pubmed.ncbi.nlm.nih.gov/18174451)\] 13. BORN GV, CROSS MJ. Effect of adenosine diphosphate on the concentration of platelets in circulating blood. Nature. 1963 Mar 09;197:974-6. \[[PubMed: 14014001](https://pubmed.ncbi.nlm.nih.gov/14014001)\] 14. Gresele P, Arnout J, Deckmyn H, Vermylen J. Mechanism of the antiplatelet action of dipyridamole in whole blood: modulation of adenosine concentration and activity. Thromb Haemost. 1986 Feb 28;55(1):12-8. \[[PubMed: 3704998](https://pubmed.ncbi.nlm.nih.gov/3704998)\] 15. By the 2019 American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2019 Apr;67(4):674-694. \[[PubMed: 30693946](https://pubmed.ncbi.nlm.nih.gov/30693946)\] 16. Lee SD, Huang WC, Peng NJ, Hu C. Dipyridamole-induced adverse effects in myocardial perfusion scans: Dynamic evaluation.